metricas
covid
Annals of Hepatology Re-evaluating the survival benefit of adding camrelizumab to TACE plus tyrosine-...
Journal Information

Statistics

Follow this link to access the full text of the article

Letters to the editor
Re-evaluating the survival benefit of adding camrelizumab to TACE plus tyrosine-kinase inhibitors in unresectable hepatocellular carcinoma: the undervalued influence of TACE frequency
Longshuang Wang, Jian Zhang, Jianfei Liu
Corresponding author
dyfyljf200201@126.com

Corresponding author.
Department of Interventional Therapy, Dalian Medical University First Affiliated Hospital, Dalian, Liaoning 116011, China
Read
146
Times
was read the article
58
Total PDF
88
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 15 9 24
2025 11 37 34 71
2025 10 29 10 39
2025 9 7 5 12

Follow this link to access the full text of the article